Introduction
Almost all hypertension treatment studies have utilised conventional sphygmomanometry to measure the effect of different drug therapies on blood pressure and morbidity and mortality. It is likely, however, that conventional peripheral blood pressure measurements are an imperfect surrogate measure of central arterial blood pressure. 1 It is also possible that various therapeutic regimes have differing effects of large vessel performance and the resulting haemodynamic indices. 2 Thus, if central arterial blood pressure could be conveniently measured, it may provide a better marker of cardiovascular risk and the response to antihypertensive and lipid lowering therapy. Nevertheless, this remains speculative because to date, the relationship between treated peripheral blood pressure measurements and simultaneous central arterial pressure estimation have not been defined in a large prospective clinical trial. This ASCOT sub-study will use non-invasive applanation tonometry to acquire peripheral (radial) arterial pressure wave forms to calculate central arterial pressure. 3 In addition, pulse wave analysis will provide information about large vessel haemodynamic performance and arterial pulse wave augmentation; a surrogate for large vessel compliance. The design of ASCOT will allow the prospective examination of the impact of two different antihypertensive therapy regimes on pulse wave morphology in a large cohort of hypertensive patients at high cardiovascular risk. The impact of statin therapy and the resultant lipid lowering on vascular function and central arterial pressure indices will also be defined. Moreover the relationship between the effects of these different therapeutic interCorrespondence: Prof Bryan Williams, Cardiovascular Research Institute, Faculty of Medicine and Biological Sciences, University of Leicester, Leicester, UK. E-mail: bw17Ȱle.ac.uk ventions on pulse wave morphology, cardiovascular function and subsequent cardiovascular outcome will be examined for the first time.
Background
When blood pressure is measured it is conveniently done so via an arm cuff with the assumption that the peripheral systemic pressure is an accurate reflection of central arterial blood pressure. However, these measurements simply record systolic and diastolic blood pressure and take no account of the 'quality' of the pulse wave. The relationship between peripheral blood pressure and central arterial blood pressure is dependent on the intrinsic haemodynamic performance of the vasculature and this relationship can be profoundly disturbed if there is evidence of vascular disease, particularly arteriosclerosis (arterial aging, arterial stiffening and loss of compliance). 2, 4 Arteriosclerosis leads to an increase in pulse wave velocity, early wave reflection and thus augmentation of the central arterial pressure. 5 This in turn leads to an increase in cardiac workload, predisposing to myocardial ischaemia and left ventricular hypertrophy. 6 Hypertension and hypercholesterolaemia are associated with accelerated aging of the vasculature and early onset arteriosclerosis. 7, 8 This suggests that patients with risk factors for arteriosclerosis may have disproportionately higher central arterial blood pressures and thus be at greater risk of premature cardiovascular morbidity and mortality. There is presently no information available regarding the relationship between treated central aortic pressure and cardiovascular risk, or whether the non-invasive assessment of central arterial blood pressure may provide a better indicator of cardiovascular outcome than conventional blood pressure measurement.
It is possible that different classes of antihypertensive therapy may produce a different relationship between central and peripheral blood pressure, ie, one agent may produce a greater or lesser fall in central pressure for any measured fall in conventionally measured peripheral blood pressure. 2 Moreover, it is conceivable that the treatment of hypercholesterolaemia may influence large vessel structure and performance and thus independently influence the relationship between peripheral and central arterial blood pressure. There is therefore an urgent need to prospectively evaluate the impact of antihypertensive therapy and lipid lowering therapy on more detailed haemodynamic indices than peripheral blood pressure alone. ASCOT provides the ideal setting to undertake such a study in that it is designed to compare two different antihypertensive therapy regimes and the impact of lipid lowering therapy with statins over a sufficiently long period (5 years). The long duration ASCOT is of crucial importance to this sub-study in that it allows sufficient time for any clinically important differences in haemodynamic performance related to structural changes (ie, arterial stiffening) and the differential impact (if any) of the various therapeutic approaches to become apparent.
Objectives of the sub-study
• To prospectively study the effects of the two different antihypertensive therapy regimes on the relationship between central and peripheral arterial blood pressure.
• To prospectively study the effects of the two different antihypertensive therapy regimes on arterial pulse wave augmentation-which is inversely related to large artery stiffness and thus, vascular aging.
• To prospectively study the effects of the two different antihypertensive therapy regimes on the diastolic pressure time interval (Buckberg ratio)-a myocardial ischaemia index that can be derived from pulse wave analysis.
• To define whether treated central arterial blood pressure is a better predictor of outcome (as defined by the primary and secondary outcome measures in the ASCOT study), when compared to treated conventional blood pressure measurements.
• To prospectively study the effects of lipid lowering therapy with a statin (atorvastatin) on the relationship between central and peripheral arterial blood pressure.
• To prospectively study the effects of lipid lowering therapy with a statin (atorvastatin) on arterial pulse wave augmentation-which is inversely related to large artery stiffness and thus, vascular aging.
• To prospectively study the effects of lipid lowering therapy with a statin (atorvastatin) on the diastolic pressure time interval (Buckberg ratio)-a myocardial ischaemia index that can be derived from pulse wave analysis.
• The Cardiovascular Research Institute, University of Leicester has a 'control' database of 500 normotensive people in whom cardiovascular risk profiling and applanation tonometry has been performed. Thus, at baseline, the pulse wave morphology and derived haemodynamic indices of hypertensive people randomised into ASCOT and this large age-matched normotensive control population will be compared. This will provide the largest ever comparative analysis between normotensive and hypertensive people with regard to detailed haemodynamic indices. Moreover, this analysis will be completed within 12 months of commencing the sub-study.
Methods and CAFE study design

Applanation tonometry and peripheral pulse wave analysis
To understand the scientific basis and appreciate the validity and power of the technology to be used in this study it is necessary to briefly review the detailed clinical information that can be determined from careful pulse wave analysis. The arterial pulse wave has a complex shape that varies with age, differs in different arteries and is markedly influenced by the presence of arterial disease, particularly arteriosclerosis or 'arterial stiffening'. [2] [3] [4] The normal pulse wave when measured at peripheral arteries comprises a systolic wave separated from a diastolic wave by the incisura which is caused by aortic valve closure. The diastolic wave is caused by reflection of the pulse wave and is important for diastolic filling of coronary arteries. Aging and/or arteriosclerosis, both lead to arterial stiffening and loss of arterial compliance, principally in the descending aorta. [2] [3] [4] [5] This leads to an increase in pulse wave velocity which causes the reflected wave to return earlier in the cardiac cycle. This leads to diminution of the diastolic wave and augmentation of the systolic wave. This in turn leads to increased systolic work (and thus left ventricular hypertrophy and increased oxygen demand) which is compounded by the decrease in diastolic filling, thus predisposing to cardiac ischaemia.
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Applanation tonometry and peripheral pulse wave analysis
The recent availability of applanation tonometry has revolutionised the assessment of peripheral pulse wave morphology. Tonometers are widely used for the measurement of intraocular pressure and have been adapted for radial artery pulse wave recording. The technique has been extensively validated and application of the probe to the radial artery has been shown to give excellent and reproducible representations of the radial pulse wave. 4, [11] [12] [13] [14] Moreover, we have confirmed that measurements by different trained operators give highly reproducible results in the same patient. 14 The present project will use a commercially available computer system linked to the arterial tonometer (Sphygmocor, PWV Medical Ltd, Australia). Brachial artery blood pressure will be measured using the automated device and standard procedure for the ASCOT study and the radial artery waveform will be recorded immediately afterwards with the tonometer. This data is then processed by the computer to yield a synthesised central arterial wave form and central aortic mean systolic and mean diastolic pressures. In addition, analysis of the waveform allows for accurate determination of the diastolic pressure time interval (DPTI) and the systolic pressure time interval (SPTI). DPTI determines myocardial blood supply and SPTI is a determinant of left ventricular load and thus myocardial demand. The quotient (DPTI/SPTI, ie, Supply/Demand) is calculated as an index of subendocardial viability. This viability ratio as named after Buckberg (the Buckberg ratio), is a sensitive marker of subendocardial ischaemia.
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Study design
Recruitment will be restricted to patients recruited into the ASCOT study in UK and Ireland. Leicester will function as the co-ordinating centre for the Conduit Artery Functional Endpoint (CAFE) sub-study and four additional centres have been invited to participate. Together these five centres will have recruited over 3000 patients into the main ASCOT study. These centres will invite their ASCOT study patients to participate in the CAFE sub-study and the target recruitment number is 3000. The CAFE sub-study has been approved by the ASCOT substudy committee and will be submitted to MREC and LRECs for ethical approval. Participating patients will be required to give informed consent. All will be established on their ASCOT study medication for a minimum of 6 months prior to recruitment into the CAFE sub-study. There are no exclusion criteria. Applanation tonometry will be performed on each patient recruited into the CAFE sub-study, by a trained observer (see below) during their routine ASCOT follow-up visit. Applanation tonometry will be performed, ideally twice per year and a minimum of once per year for the duration of the follow-up period of the ASCOT study (5 years). Consecutive measurements will be separated by a minimum of a 6-month interval and when only one set of measurements/patient/year is available, the interval between measurements should ideally be 1 year. Data will be stored on a dedicated computer at each participating centre and transferred by diskette to the substudy co-ordinating centre (Leicester) every 6 months. The quality of the recordings will be monitored in Leicester, with external advice from Prof Michael O'Rourke. Applanation tonometry recordings deemed to be of inadequate quality will be repeated within 6 months.
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Making the measurements: applanation tonometry
The acquisition of a recordable arterial pulse wave usually takes no more than 5 min. The measurements will be taken after patients have been seated for 5 min. Two applanation tonometry measurements will be recorded 5 min apart. After measurement of the blood pressure as per ASCOT protocol, applanation tonometry is performed by gently placing a small pencil-like Doppler probe on the skin overlying the radial artery. The pulse wave morphology is recorded within the attached note-book computer (the computer, software and (Doppler) tonometer probe form the Sphygmocor apparatus). Two measurements would be taken for each patient at time intervals as specified above, at a routine visit to their ASCOT study centre. The Sphygmocor apparatus and computer will be provided for each participating study centre. The Leicester centre will provide on-site training in the use of applanation tonometry for all participating centres and back-up support/advice on a day-to-day basis. All the other patient data required for detailed analysis will be recorded on the ASCOT database in the usual way. No additional measurements/assays are required for this study.
Statistical method/data analysis
A study of this design or scale has never previously been performed, thus it is difficult to estimate its power. However, we have shown clear differences in the haemodynamic indices of hypertensive vs normotensive patients in small studies, using only 40 patients in each group. 8 If the two different antihypertensive therapy regimes, and/or lipid lowering therapy produces differences in the relationship between peripheral and central aortic pressure of 10% or more, the study of 3000 patients would have more than 90% power to detect this difference.
Discussion
Sphygmomanometric measurements of peripheral blood pressure (usually brachial) have revealed peripheral blood pressure to be a strong predictor of cardiovascular morbidity and mortality. However, it is not the peripheral pressure per se that accounts for this increase in cardiovascular morbidity and mortality. On the contrary, blood pressure is measured peripherally for convenience and simplicity and acts as a surrogate for central arterial blood pressure. Nevertheless, the relationship between peripheral and central blood pressure has not been measured in clinical trials and cannot be assumed to be constant because it is influenced by many factors, including the age and haemodynamic performance of the aorta. [1] [2] [3] [4] [5] [6] [7] [8] Almost all of the change in central arterial pulse wave morphology occurs as a consequence of changes in pulse wave reflection from central 
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Journal of Human Hypertension arteries and lower limb vessels. [10] [11] [12] There is remarkable constancy in the relationship between the central aortic pressure waveform and the radial pulse wave. [10] [11] [12] This observation has been exploited to allow the central arterial pressure wave to be accurately synthesised from measurements of the radial pulse wave. The validity of the measurements is dependent on this important assumption which has been subjected to strict validation. In a variety of studies in man, direct measurements of the central arterial pressure wave and simultaneous direct measurements of the radial artery pressure wave have been made during cardiac catheterisation in patients with various diseases both before and after the administration of drugs that influence vascular tone. 2, 3 These studies have confirmed that applanation tonometry can be used to obtain accurate measurements of the radial artery wave form and that changes in the morphology of this wave accurately reflect changes in central arterial wave morphology.
The central aortic wave form synthesised from peripheral pulse wave tonometry and brachial blood pressure provides not only systolic and diastolic central aortic blood pressure but also diastolic and systolic pressure time intervals. DPTI determines myocardial blood supply and SPTI is a determinant of left ventricular load and thus myocardial demand. Thus, the ratio of DPTI/SPTI is an index of myocardial oxygen supply and demand. This viability ratio, the Buckberg ratio, is a sensitive marker of subendocardial ischaemia. 15, 16 Thus, additional data regarding the status of the cardiovascular system can be derived from the peripheral arterial pulse wave. Operators can be easily trained in the use of this technique and the technique yields excellent inter-observer reproducibility when assessing multiple subjects on different days.
14 In this regard, the technique appears to be well suited for the study of derived central aortic blood pressure and related haemodynamic indices in a multicentre clinical trial such as ASCOT.
The haemodynamic performance of large blood vessels deteriorates with aging as a consequence of structural modifications within the vessel wall and deterioration in endothelial function. [1] [2] [3] [4] [5] [6] [7] [8] Both of these structural and functional changes are accelerated in patients with hypertension 8 and may be amenable to favourable modification by drug therapy. 17 This sub-study will evaluate the potential for the different antihypertensive therapeutic regimes in ASCOT to differentially effect vascular structure and function and thus better preserve or indeed improve the haemodynamic performance of large blood vessels. Such a finding would have major implications for the choice of drug therapy in aging populations. Moreover, hypercholesterolaemia has been shown to impair endothelial function and may accelerate vascular aging. This study will uniquely define whether improved control of blood cholesterol with statin therapy (atorvastatin) will better preserve vascular function in hypertensive people.
In conclusion, the preservation of vascular function has for too long been ignored as an important objective of antihypertensive and lipid lowering therapies. This study will uniquely define whether the choice of antihypertensive therapy or the decision to treat elevated blood cholesterol will impact on the age-related deterioration in vascular function in hypertensive people at high cardiovascular risk.
